Shares of enCore Energy (EU.V) jumped 7.3% to CA$1.77 on September 3 after Jefferies initiated coverage with a Buy rating and a US$1.44 price target, lending the small uranium miner its first major Wall Street endorsement. The stock trades well above Jefferies' target but well below InvestingPro's fair-value estimate of US$2.03, suggesting the market is still pricing in substantial uncertainty. The question for shareholders: does a single analyst call change the math on a company that is burning cash while uranium fundamentals look increasingly bullish?
A Rare Wall Street Spotlight on a Tiny Uranium Producer. Jefferies noted that permitting remains a key risk , but the initiation is part of a broader sweep across critical-metals names — Jefferies simultaneously started coverage on peers like NexGen Energy and Uranium Energy Corp. The firm described Uranium Energy as the country's largest uranium company, with around 12 million pounds per year of licensed capacity. enCore is far smaller, but it occupies a similar niche: it extracts uranium across three U.S. states using a low-cost, low-impact method called in-situ recovery, which accounts for roughly 60% of global uranium production.
The Supply Gap Working in enCore's Favor. U.S. domestic uranium production runs at roughly 200,000 pounds per year against reactor requirements of 40–44 million pounds, with demand projected to grow toward 48 million pounds annually.
Uranium spot prices sat at $89.49/lb as of September 3 — well above the $72–$78 range earlier in 2026 — and long-term uranium prices reached a historic high of $97.00 in July 2026. That pricing tailwind benefits any domestic producer with contracted utility sales, which enCore claims to have.
Permits Are Advancing, but Cash Is Draining. The NRC issued a 20-year license renewal for enCore's Dewey Burdock project in South Dakota in June 2026, and the project has now received all necessary federal permits.
State-level permitting in South Dakota is still required before full operations begin. Meanwhile, enCore is "quickly burning through cash," and the stock has declined over 50% year-to-date, even as revenue grew 24% over the last twelve months.
The company carries a US$115 million convertible note at 5.5% , a heavy debt load relative to its roughly $360 million market cap.
The Bottom Line: Good Story, Execution Still Unproven. enCore touts operational capacity of up to 3.6 million pounds per year , but actual output remains a fraction of that. Uranium's macro setup is the strongest in a generation. Whether enCore can scale production fast enough to capture it — before the cash runs out — is the bet Jefferies is making.